|Baxter Ventures||Vice President and Head||USA|
Anne E. Sissel, CFA
Anne Sissel is the Vice President and Head of Baxter Ventures. Baxter Ventures is the $200 million venture capital fund of Baxter International, investing in companies with innovative technologies, products and/or therapies with the ability to improve patient care globally and maximize value for investors and entrepreneurs.
Previous to Baxter, Anne was on the founding team and executive team for Veracyte, Inc. (now NASDAQ: VCYT). Anne led the finance and business development organization and was a cross-functional leader from early discovery through commercialization. Prior to Veracyte, Anne worked in the Investment Banking Division of Goldman, Sachs & Co. in New York and San Francisco, completing over $200bn in financing and M&A transactions.
Anne holds an MBA from the Wharton School of the University of Pennsylvania and a BS in Finance from Indiana University. She was selected to Crain’s Chicago Business Top 40 Under 40 in 2016 and their Top 50 in Tech in 2015. Anne’s current Board and Observation roles representing Baxter include: Kit Check, Medasense, Opsonix, Sanifit, TVA Medical and VitalConnect.